107 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
EC Ecopetrol S.A. $25.79 $53.02B Downtrend
Article Searches
The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering http://feeds.benzinga.com/~r/benzinga/~3/luqnX1mkMuQ/the-daily-biotech-pulse-arsanis-completes-x4-merger-ec-nod-for-roche- Mar 14, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech stocks hitting 52-week highs on March 13)

read more

EC OK's Merck's Keytruda in first-line lung cancer https://seekingalpha.com/news/3442663-ec-oks-mercks-keytruda-first-line-lung-cancer?source=feed_news_all Mar 14, 2019 - As expected, the European Commision approves Merck's (NYSE:MRK) Keytruda (pembrolizumab), combined with carboplatin and Celgene's (NASDAQ:CELG) Abraxane (paclitaxel protein-bound), for the first-line
EC OK's expanded use for Roche's Hemlibra https://seekingalpha.com/news/3442658-ec-oks-expanded-use-roches-hemlibra?source=feed_news_all Mar 14, 2019 - The European Commission (EC) approves Roche's (OTCQX:RHHBY) Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in people with severe haemophilia A (congenital factor VIII defic
Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC http://www.zacks.com/stock/news/358374/roches-rhhby-tecentriq-gets-ec-nod-for-first-line-nsclc?cid=CS-ZC-FT-358374 Mar 08, 2019 - Roche (RHHBY) obtains approval for the label expansion of Tecentriq in Europe. The company also submits its sNDA for leukemia drug, Venclexta.
The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings http://feeds.benzinga.com/~r/benzinga/~3/D7voBuYZzwY/the-daily-biotech-pulse-tonix-gets-european-patent-ec-nod-for-roche-i Mar 08, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours:

Scaling The Peaks

(Biotech stocks hitting 52-week highs on March 7)

read more

Ecopetrol Allocates $500M of Capital Outlay for Fracking http://www.zacks.com/stock/news/358056/ecopetrol-allocates-%24500m-of-capital-outlay-for-fracking?cid=CS-ZC-FT-358056 Mar 07, 2019 - Ecopetrol (EC) is set to invest $500 million toward exploring unconventional deposits in the 2019-2021 time frame, beginning with shale pilot programs in Colombia???s shale-rich Magadalena Valley basin.
EC fine for Autoliv lower than anticipated https://seekingalpha.com/news/3439812-ec-fine-autoliv-lower-anticipated?source=feed_news_all Mar 05, 2019 - Autoliv (NYSE:ALV) announces that the European Commission completed its investigation into suppliers of occupant safety systems. The EU Commission has decided to impose a fine of €179M to the company
Ecopetrol SA (EC) CEO Felipe Bayón on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4244902-ecopetrol-sa-ec-ceo-felipe-bayon-q4-2018-results-earnings-call-transcript?source=feed_sector_transcripts Feb 27, 2019 - Ecopetrol SA (NYSE:EC) Q4 2018 Earnings Conference Call February 27, 2019, 09:30 ET Company Participants Felipe Bayón - CEO Jorge Calvache - VP, Exploration Rafael Guzman - Technical Vice-President Al
Seattle Genetics' Adcetris Gets EC Nod for Label Expansion http://www.zacks.com/stock/news/354019/seattle-genetics-adcetris-gets-ec-nod-for-label-expansion?cid=CS-ZC-FT-354019 Feb 12, 2019 - Seattle Genetics' (SGEN) partner, Takeda Pharmaceutical receives EC approval for Adcetris in combination with AVD to treat adults with previously untreated CD30+ stage IV cHL.
EC OKs expanded use for Bristol-Myers' Sprycel https://seekingalpha.com/news/3431582-ec-oks-expanded-use-bristol-myers-sprycel?source=feed_news_all Feb 11, 2019 - The European Commission (EC) approves Bristol-Myers Squibb's (NYSE:BMY) Sprycel (dasatinib), combined with chemo, for the treatment pediatric patients with newly diagnosed Philadelphia chromos

Pages: 1234567...11

<Page 2>